AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
INTRACELLULAR TARGETS IN HEME PROTEIN-INDUCED RENAL INJURY
Authors: NATH KA GRANDE JP CROATT AJ LIKELY S HEBBEL RP ENRIGHT H
Citation: Ka. Nath et al., INTRACELLULAR TARGETS IN HEME PROTEIN-INDUCED RENAL INJURY, Kidney international, 53(1), 1998, pp. 100-111
THE IRON CHELATOR L1 POTENTIATES OXIDATIVE DNA-DAMAGE IN IRON-LOADED LIVER-CELLS
Authors: CRAGG L HEBBEL RP MILLER W SOLOVEY A SELBY S ENRIGHT H
Citation: L. Cragg et al., THE IRON CHELATOR L1 POTENTIATES OXIDATIVE DNA-DAMAGE IN IRON-LOADED LIVER-CELLS, Blood, 92(2), 1998, pp. 632-638
AUTOIMMUNE PHENOMENA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: ENRIGHT H MILLER W
Citation: H. Enright et W. Miller, AUTOIMMUNE PHENOMENA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 24(5-6), 1997, pp. 483-489
LEUKOCYTE REDUCTION AND ULTRAVIOLET-B IRRADIATION OF PLATELETS TO PREVENT ALLOIMMUNIZATION AND REFRACTORINESS TO PLATELET TRANSFUSIONS
Authors: MCFARLAND J MENITOVE J KAGEN L BRAINE H KICKLER T NESS P FULLER A SLICHTER S GERNSHEIMER T TOWNSENDMCCALL D KAO KJ NOYES W WEINER R HUDSON S WALDMANSLONE A SCHIFFER C LEE E NORRIS D MCCULLOUGH J ENRIGHT H LENNON S CLAY M WOODSON R MEISCH M NOORDSIJ P DAVIS K MICKEL M GILLESPIE MJ NG G PARKER S CORLEY S RODEY G KAO KJ SELL J NEMO G FOLLMANN D HERNANDEZ M HOLLINGSWORTH C KLEIN H DUTCHER J FRATANTONI J KRUSKALL M MACKLIN R STRAUSS R WITTES J
Citation: J. Mcfarland et al., LEUKOCYTE REDUCTION AND ULTRAVIOLET-B IRRADIATION OF PLATELETS TO PREVENT ALLOIMMUNIZATION AND REFRACTORINESS TO PLATELET TRANSFUSIONS, The New England journal of medicine, 337(26), 1997, pp. 1861-1869
INFUSIBLE PLATELET MEMBRANE (IPM) FOR CONTROL OF BLEEDING IN THROMBOCYTOPENIC PATIENTS
Authors: SCIGLIANO E ENRIGHT H TELEN M GOODNOUGH LT DIPERSIO J KOLODZIEJ M MURPHY W BILLETT H HOURANIEH A KIM BK SWISHER SN
Citation: E. Scigliano et al., INFUSIBLE PLATELET MEMBRANE (IPM) FOR CONTROL OF BLEEDING IN THROMBOCYTOPENIC PATIENTS, Blood, 90(10), 1997, pp. 1170-1170
MODERATE TO SEVERE REACTIONS TO PLATELET TRANSFUSION - EXPERIENCE OF THE TRAP MULTICENTER TRIAL
Authors: ENRIGHT H GERNSHEIMER T MCCULLOUGH J WOODSON R SLICHTER S DAVIS K
Citation: H. Enright et al., MODERATE TO SEVERE REACTIONS TO PLATELET TRANSFUSION - EXPERIENCE OF THE TRAP MULTICENTER TRIAL, Blood, 90(10), 1997, pp. 1172-1172
UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES-CURRENT STATUS
Authors: DAVIES SM WAGNER JE WEISDORF DJ SHU XO BLAZAR BR ENRIGHT H MCGLAVE PB RAMSAY NKC
Citation: Sm. Davies et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES-CURRENT STATUS, Leukemia & lymphoma, 23(3-4), 1996, pp. 221-226
RELATED DONOR MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA - PATIENT CHARACTERISTICS PREDICTIVE OF OUTCOME
Authors: ENRIGHT H DANIELS K ARTHUR DC DUSENBERY KE KERSEY JH KIM T MILLER WJ RAMSAY NKC VERCELLOTTI GM WEISDORF DJ MCGLAVE PB
Citation: H. Enright et al., RELATED DONOR MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA - PATIENT CHARACTERISTICS PREDICTIVE OF OUTCOME, Bone marrow transplantation, 17(4), 1996, pp. 537-542
OUTCOME OF 2ND BONE-MARROW TRANSPLANTATION FOLLOWING A UNIFORM CONDITIONING REGIMEN AS THERAPY FOR MALIGNANT RELAPSE
Authors: CHIANG KY WEISDORF DJ DAVIES SM ENRIGHT H KERSEY JH MCGLAVE PB MILLER W RAMSAY NKC STEINBUCH M WAGNER JE BLAZAR BR
Citation: Ky. Chiang et al., OUTCOME OF 2ND BONE-MARROW TRANSPLANTATION FOLLOWING A UNIFORM CONDITIONING REGIMEN AS THERAPY FOR MALIGNANT RELAPSE, Bone marrow transplantation, 17(1), 1996, pp. 39-42
PREFERENTIAL TARGETING OF OXIDATIVE BASE DAMAGE TO INTERNUCLEOSOMAL DNA
Authors: ENRIGHT H MILLER WJ HAYS R FLOYD RA HEBBEL RP
Citation: H. Enright et al., PREFERENTIAL TARGETING OF OXIDATIVE BASE DAMAGE TO INTERNUCLEOSOMAL DNA, Carcinogenesis, 17(5), 1996, pp. 1175-1177
RELAPSE AFTER NON-T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - EARLY TRANSPLANTATION USE OF ANUNRELATED DONOR, AND CHRONIC GRAFT-VERSUS-HOST DISEASE ARE PROTECTIVE
Authors: ENRIGHT H DAVIES SM DEFOR T SHU X WEISDORF D MILLER W RAMSAY NKC ARTHUR D VERFAILLIE C MILLER J KERSEY J MCGLAVE P
Citation: H. Enright et al., RELAPSE AFTER NON-T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA - EARLY TRANSPLANTATION USE OF ANUNRELATED DONOR, AND CHRONIC GRAFT-VERSUS-HOST DISEASE ARE PROTECTIVE, Blood, 88(2), 1996, pp. 714-720
INCREASED SENSITIVITY TO OXIDATIVE DNA-DAMAGE WITH DEFECTIVE P53 RESPONSE BUT NORMAL DNA-REPAIR CAPACITY IN FANCONI-ANEMIA COMPLEMENTATION GROUP-A CELLS
Authors: ENRIGHT H MILLER WJ CRAGG L SELBY S HEBBEL RP
Citation: H. Enright et al., INCREASED SENSITIVITY TO OXIDATIVE DNA-DAMAGE WITH DEFECTIVE P53 RESPONSE BUT NORMAL DNA-REPAIR CAPACITY IN FANCONI-ANEMIA COMPLEMENTATION GROUP-A CELLS, Blood, 88(10), 1996, pp. 1221-1221
THE IRON CHELATOR L1 POTENTIATES IRON-MEDIATED OXIDATIVE DNA-DAMAGE
Authors: CRAGG L HEBBEL RP SOLOVEY A MILLER WJ ENRIGHT H
Citation: L. Cragg et al., THE IRON CHELATOR L1 POTENTIATES IRON-MEDIATED OXIDATIVE DNA-DAMAGE, Blood, 88(10), 1996, pp. 2573-2573
OUTCOME FOLLOWING MARROW TRANSPLANTATION FOR PATIENTS WITH AML WITH PRIOR CNS INVOLVEMENT
Authors: CRAGG L WEISDORF D ORCHARD P MILLER JS RAMSAY NKC DEFORS T ENRIGHT H
Citation: L. Cragg et al., OUTCOME FOLLOWING MARROW TRANSPLANTATION FOR PATIENTS WITH AML WITH PRIOR CNS INVOLVEMENT, Blood, 88(10), 1996, pp. 2722-2722
WHITE CELL-REDUCTION IN PLATELET CONCENTRATES AND PACKED RED-CELLS BYFILTRATION - A MULTICENTER CLINICAL-TRIAL
Authors: KAO KJ MICKEL M BRAINE HG DAVIS K ENRIGHT H GERNSHEIMER T GILLESPIE MJ KICKLER TS LEE EJ MCCULLOUGH JJ MCFARLAND JG NEMO GJ NOYES WD SCHIFFER CA SELL K SLICHTER SJ WOODSON RD
Citation: Kj. Kao et al., WHITE CELL-REDUCTION IN PLATELET CONCENTRATES AND PACKED RED-CELLS BYFILTRATION - A MULTICENTER CLINICAL-TRIAL, Transfusion, 35(1), 1995, pp. 13-19
PARANEOPLASTIC AUTOIMMUNE PHENOMENA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
Authors: ENRIGHT H JACOB HS VERCELLOTTI G HOWE R BELZER M MILLER W
Citation: H. Enright et al., PARANEOPLASTIC AUTOIMMUNE PHENOMENA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - RESPONSE TO IMMUNOSUPPRESSIVE THERAPY, British Journal of Haematology, 91(2), 1995, pp. 403-408
RESPONSE TO THALIDOMIDE THERAPY IN PATIENTS WITH REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: BROWNE PV WAGNER J WEISDORF DJ DEFOR T MILLER WJ DAVIES SM FILIPOVICH A MCGLAVE PB RAMSAY NKC ENRIGHT H
Citation: Pv. Browne et al., RESPONSE TO THALIDOMIDE THERAPY IN PATIENTS WITH REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(10), 1995, pp. 1577-1577
LATE INFECTIONS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - COMPARISON OF INCIDENCE IN RELATED AND UNRELATED DONOR TRANSPLANT RECIPIENTS
Authors: OCHS L SHU XO MILLER J ENRIGHT H WAGNER J FILIPOVICH A MILLER W WEISDORF D
Citation: L. Ochs et al., LATE INFECTIONS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - COMPARISON OF INCIDENCE IN RELATED AND UNRELATED DONOR TRANSPLANT RECIPIENTS, Blood, 86(10), 1995, pp. 3979-3986
EFFECT OF PYRUVATE ON OXIDANT INJURY TO ISOLATED AND CELLULAR DNA
Authors: NATH KA ENRIGHT H NUTTER L FISCHEREDER M ZOU JN HEBBEL RP
Citation: Ka. Nath et al., EFFECT OF PYRUVATE ON OXIDANT INJURY TO ISOLATED AND CELLULAR DNA, Kidney international, 45(1), 1994, pp. 166-176
QUANTIFICATION OF RESIDUAL LEUKOCYTES BY NAGOETTE AND PROPIDIUM IODIDE TECHNIQUES IN FILTERED PLATELET COMPONENTS
Authors: LENNON S CLAY M ENRIGHT H MCCULLOUGH J
Citation: S. Lennon et al., QUANTIFICATION OF RESIDUAL LEUKOCYTES BY NAGOETTE AND PROPIDIUM IODIDE TECHNIQUES IN FILTERED PLATELET COMPONENTS, Transfusion, 34(10), 1994, pp. 190000010-190000010
INTERNUCLEOSOMAL CLEAVAGE OF DNA AS THE SOLE CRITERION FOR APOPTOSIS MAY BE ARTIFACTUAL
Authors: ENRIGHT H HEBBEL RP NATH KA
Citation: H. Enright et al., INTERNUCLEOSOMAL CLEAVAGE OF DNA AS THE SOLE CRITERION FOR APOPTOSIS MAY BE ARTIFACTUAL, The Journal of laboratory and clinical medicine, 124(1), 1994, pp. 63-68
2ND BONE-MARROW TRANSPLANT (BMT) AS THERAPY FOR MALIGNANT RELAPSE
Authors: CHIANG KY WEISDORF DJ DAVIES SM MILLER W ENRIGHT H WAGNER JE RAMSAY NKC KERSEY JH MCGLAVE PB BLAZAR RB
Citation: Ky. Chiang et al., 2ND BONE-MARROW TRANSPLANT (BMT) AS THERAPY FOR MALIGNANT RELAPSE, Blood, 84(10), 1994, pp. 10000214-10000214
HIGH-DOSE DONOR MONONUCLEAR CELL INFUSION IN POSTTRANSPLANT RELAPSED AML MDS/
Authors: VERFAILLIE CM WEISDORF D MCGLAVE PB VERCELLOTTI GM ENRIGHT H BURNS L MILLER JS
Citation: Cm. Verfaillie et al., HIGH-DOSE DONOR MONONUCLEAR CELL INFUSION IN POSTTRANSPLANT RELAPSED AML MDS/, Blood, 84(10), 1994, pp. 10000333-10000333
HIGHER INCIDENCE OF RELAPSE IN RELATED COMPARED WITH UNRELATED DONOR RECIPIENTS FOLLOWING ALLOGENEIC MARROW TRANSPLANT FOR CML - ANALYSIS IN 290 PATIENTS
Authors: ENRIGHT H DAVIES S SHU X MILLER W WEISDORF D VERFAILLIE C MILLER J ARTHUR D DUSENBURY K RAMSAY N KERSEY J VERCELLOTTI G MCGLAVE P
Citation: H. Enright et al., HIGHER INCIDENCE OF RELAPSE IN RELATED COMPARED WITH UNRELATED DONOR RECIPIENTS FOLLOWING ALLOGENEIC MARROW TRANSPLANT FOR CML - ANALYSIS IN 290 PATIENTS, Blood, 84(10), 1994, pp. 10000336-10000336
EXCESS HEMOLYSIS IN AS-1 RBCS MAY BE UNDETECTED
Authors: LENNON S CLAY M MCCULLOUGH J ENRIGHT H
Citation: S. Lennon et al., EXCESS HEMOLYSIS IN AS-1 RBCS MAY BE UNDETECTED, Blood, 84(10), 1994, pp. 10000469-10000469
Risultati: 1-25 | 26-34